A case of hereditary hemorrhagic telangiectasia associated with crohn's disease successfully treated with infliximab

American Journal of Gastroenterology

Volumn 105, Issue 8, 2010, Pages 1904-

  Papa, Alfredo ^a   Felice, Carla ^a   Marzo, Manuela ^a   Guidi, Luisa ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HEMOGLOBIN; INFLIXIMAB; IRON; STEROID;

ABDOMINAL PAIN; CROHN DISEASE; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; EPISTAXIS; FAMILY HISTORY; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILEUM; IRON THERAPY; LETTER; LIP; MAINTENANCE THERAPY; MICROCYTIC ANEMIA; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RENDU OSLER WEBER DISEASE; TONGUE;

EID: 77955366793     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.155     Document Type: Letter

References (3)

1. Govani FS, Shovlin CL. Hereditary haemorragictelangiectasia: a clinical and scientific review.Eur J Hum Genet 2009; 17: 860-871
2. Abdalla SA, Letarte M. Hereditary haemorrhagictelangiectasia: current views on geneticsand mechanism of disease. J Med Genet2006; 43: 97-110.
3. Li C, Guo B, Ding S et al. TNF alpha downregulatesCD105 expression in vascularendothelial cells: a comparative study with TGFbeta 1. Anticancer Res 2003; 23: 1189-1196